Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

65 results about "Lanosterol" patented technology

Lanosterol is a tetracyclic triterpenoid and is the compound from which all animal and fungal steroids are derived. By contrast plant steroids are produced via cycloartenol. Researchers who have pioneered the use of lanosterol in eyedrop form — to treat or prevent cataracts — include Kang Zhang and Ling Zhao.

Method for separating and extracting cholesterol in lanolin alcohol

InactiveCN101817859AAvoid disadvantages such as being vulnerable to damageLight colorSteroidsLanosterolDistillation
The invention relates to a method for separating and extracting cholesterol in lanolin alcohol, which comprises the following steps: carrying out molecular distillation on lanolin alcohol, collecting the light-phase fraction which is refined lanolin alcohol, heating the refined lanolin alcohol in a mixed solvent of methanol and acetone until the refined lanolin alcohol is completely dissolved, and cooling to cooling temperature, wherein the remainder of the filtrate after reduced pressure distillation is the primary concentrate of cholesterol; heating to dissolve the primary concentrate of cholesterol in acetone, cooling to precipitate, filtering, and carrying out reduced pressure distillation on the filtrate to recover the solvent, wherein the balance is the secondary concentrate of cholesterol; heating to dissolve the secondary concentrate of cholesterol in an alcohol solvent, cooling to cooling temperature, keeping the temperature for 6-12 hours, and vacuum-filtering to obtain the white acerose cholesterol crude product; and recrystallizing the cholesterol crude product through a methanol-acetone mixed solvent to obtain the refined cholesterol product. The refined cholesterol product selectively recrystallizes through the solvent to obtain the byproduct lanosterol accounting for 63-70% and the cholesterol product of which the purity is more than 90%.
Owner:TIANJIN UNIV

Construction method of escherichia coli bacterial strain for generating lanosterol

The invention relates to a construction method of an escherichia coli bacterial strain for generating lanosterol. The construction method comprises the steps of optimizing a codon of squalene epoxidase of methylococcus capsulatus according to an escherichia coli codon, and performing PCR amplification to obtain a squalene epoxidase genetic fragment; performing PCR amplification to obtain NADPH-cytochrome P450 reductase, and lanosterol synthetase genetic fragments, performing merging to obtain a DNA fragment SE-CPR-LS, cloning the SE-CPR-LS fragment to a vector pet21c by a restriction enzyme cutting connection method, and constructing an expression vector pet21c-SE-CPR-LS; cloning the squalene synthase genetic fragment to the vector pACYCduet-1 by a homologous recombination method, and constructing an expression vector pACYCduet-SS; and transforming the vectors pet21c-SE-CPR-LS and pACYCduet-SS into escherichia coli competence cells, so as to obtain the escherichia coli bacterial strainfor generating lanosterol. Through an exogenous plasmid transforming method, an escherichia coli BL21(DE3) system is improved, so that synthesis of the lanosterol can be realized; and through a codonoptimization technique, the expression level of exogenous genes in an escherichia coli system can be increased.
Owner:XUZHOU NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products